H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. Census population 292,449. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Jersey City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Jersey City storefront.
Biologic Solutions for Chronic Wounds in Jersey City, NJ for clinics & physicians. Biologic solutions for… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Jersey City is 26.2% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. New Jersey is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for biologic solutions chronic wounds, not a walk-in clinic.
National Biologic Solutions for Chronic Wounds notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Jersey City we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure.
If you already buy biologic solutions chronic wounds elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 9.6% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 9.6% of adults — 2.4 points below the U.S. 12% figure. Obesity is 26.2%; arthritis is 14.6%. That is place-level BRFSS modeling, not a clinic census and not a Jersey City trial.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including New Jersey. There is no Jersey City storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a New Jersey compliance risk.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
If you operate in New Jersey and another MAC state, say it on the first call. JL will not port 1:1. We would rather split utilization than watch a sister clinic copy Jersey City tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Jersey City, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Jersey City is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Jersey City — 2.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Jersey City. Useful for joint-program math; still needs a diagnosis and privileging.
No Jersey City storefront. Joe Bradley is an active practice owner. biologic solutions chronic wounds stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.